Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64


SYNGAP1 heterozygosity disrupts sensory processing by reducing touch-related activity within somatosensory cortex circuits.

Michaelson SD, Ozkan ED, Aceti M, Maity S, Llamosas N, Weldon M, Mizrachi E, Vaissiere T, Gaffield MA, Christie JM, Holder JL Jr, Miller CA, Rumbaugh G.

Nat Neurosci. 2018 Dec;21(12):1-13. doi: 10.1038/s41593-018-0268-0. Epub 2018 Nov 21.


The role of nonmuscle myosin II in polydrug memories and memory reconsolidation.

Briggs SB, Hafenbreidel M, Young EJ, Rumbaugh G, Miller CA.

Learn Mem. 2018 Aug 16;25(9):391-398. doi: 10.1101/lm.046763.117. Print 2018 Sep.


Social stress-potentiated methamphetamine seeking.

Blouin AM, Pisupati S, Hoffer CG, Hafenbreidel M, Jamieson SE, Rumbaugh G, Miller CA.

Addict Biol. 2018 Aug 14. doi: 10.1111/adb.12666. [Epub ahead of print]


Improved Scalability of Neuron-Based Phenotypic Screening Assays for Therapeutic Discovery in Neuropsychiatric Disorders.

Spicer TP, Hubbs C, Vaissiere T, Collia D, Rojas C, Kilinc M, Vick K, Madoux F, Baillargeon P, Shumate J, Martemyanov KA, Page DT, Puthanveettil S, Hodder P, Davis R, Miller CA, Scampavia L, Rumbaugh G.

Mol Neuropsychiatry. 2018 Feb;3(3):141-150. doi: 10.1159/000481731. Epub 2017 Nov 17.


Species-conserved SYNGAP1 phenotypes associated with neurodevelopmental disorders.

Kilinc M, Creson T, Rojas C, Aceti M, Ellegood J, Vaissiere T, Lerch JP, Rumbaugh G.

Mol Cell Neurosci. 2018 Sep;91:140-150. doi: 10.1016/j.mcn.2018.03.008. Epub 2018 Mar 24. Review.


The first international conference on SYNGAP1-related brain disorders: a stakeholder meeting of families, researchers, clinicians, and regulators.

Weldon M, Kilinc M, Lloyd Holder J Jr, Rumbaugh G.

J Neurodev Disord. 2018 Feb 5;10(1):6. doi: 10.1186/s11689-018-9225-1. Review.


Publisher Correction: An interactive framework for whole-brain maps at cellular resolution.

Fürth D, Vaissière T, Tzortzi O, Xuan Y, Märtin A, Lazaridis I, Spigolon G, Fisone G, Tomer R, Deisseroth K, Carlén M, Miller CA, Rumbaugh G, Meletis K.

Nat Neurosci. 2018 Jun;21(6):895. doi: 10.1038/s41593-017-0058-0.


An interactive framework for whole-brain maps at cellular resolution.

Fürth D, Vaissière T, Tzortzi O, Xuan Y, Märtin A, Lazaridis I, Spigolon G, Fisone G, Tomer R, Deisseroth K, Carlén M, Miller CA, Rumbaugh G, Meletis K.

Nat Neurosci. 2018 Jan;21(1):139-149. doi: 10.1038/s41593-017-0027-7. Epub 2017 Dec 4. Erratum in: Nat Neurosci. 2017 Dec 18;:.


Susceptibility and Resilience to Posttraumatic Stress Disorder-like Behaviors in Inbred Mice.

Sillivan SE, Joseph NF, Jamieson S, King ML, Chévere-Torres I, Fuentes I, Shumyatsky GP, Brantley AF, Rumbaugh G, Miller CA.

Biol Psychiatry. 2017 Dec 15;82(12):924-933. doi: 10.1016/j.biopsych.2017.06.030. Epub 2017 Jul 8.


Atypical Endocannabinoid Signaling Initiates a New Form of Memory-Related Plasticity at a Cortical Input to Hippocampus.

Wang W, Jia Y, Pham DT, Palmer LC, Jung KM, Cox CD, Rumbaugh G, Piomelli D, Gall CM, Lynch G.

Cereb Cortex. 2018 Jul 1;28(7):2253-2266. doi: 10.1093/cercor/bhx126.


Memory disrupting effects of nonmuscle myosin II inhibition depend on the class of abused drug and brain region.

Briggs SB, Blouin AM, Young EJ, Rumbaugh G, Miller CA.

Learn Mem. 2017 Jan 17;24(2):70-75. doi: 10.1101/lm.043976.116. Print 2017 Feb.


Nonmuscle myosin II inhibition disrupts methamphetamine-associated memory in females and adolescents.

Young EJ, Briggs SB, Rumbaugh G, Miller CA.

Neurobiol Learn Mem. 2017 Mar;139:109-116. doi: 10.1016/j.nlm.2017.01.001. Epub 2017 Jan 7.


Nonmuscle myosin IIB as a therapeutic target for the prevention of relapse to methamphetamine use.

Young EJ, Blouin AM, Briggs SB, Sillivan SE, Lin L, Cameron MD, Rumbaugh G, Miller CA.

Mol Psychiatry. 2016 May;21(5):615-23. doi: 10.1038/mp.2015.103. Epub 2015 Aug 4.


Prioritizing the development of mouse models for childhood brain disorders.

Ogden KK, Ozkan ED, Rumbaugh G.

Neuropharmacology. 2016 Jan;100:2-16. doi: 10.1016/j.neuropharm.2015.07.029. Epub 2015 Jul 29. Review.


Input-specific regulation of hippocampal circuit maturation by non-muscle myosin IIB.

Ozkan ED, Aceti M, Creson TK, Rojas CS, Hubbs CR, McGuire MN, Kakad PP, Miller CA, Rumbaugh G.

J Neurochem. 2015 Aug;134(3):429-44. doi: 10.1111/jnc.13146. Epub 2015 May 29.


Pharmacological Selectivity Within Class I Histone Deacetylases Predicts Effects on Synaptic Function and Memory Rescue.

Rumbaugh G, Sillivan SE, Ozkan ED, Rojas CS, Hubbs CR, Aceti M, Kilgore M, Kudugunti S, Puthanveettil SV, Sweatt JD, Rusche J, Miller CA.

Neuropsychopharmacology. 2015 Sep;40(10):2307-16. doi: 10.1038/npp.2015.93. Epub 2015 Apr 3.


Neuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment.

Zhou M, Ottenberg G, Sferrazza GF, Hubbs C, Fallahi M, Rumbaugh G, Brantley AF, Lasmézas CI.

Brain. 2015 Apr;138(Pt 4):992-1008. doi: 10.1093/brain/awv002. Epub 2015 Feb 11.


Syngap1 haploinsufficiency damages a postnatal critical period of pyramidal cell structural maturation linked to cortical circuit assembly.

Aceti M, Creson TK, Vaissiere T, Rojas C, Huang WC, Wang YX, Petralia RS, Page DT, Miller CA, Rumbaugh G.

Biol Psychiatry. 2015 May 1;77(9):805-15. doi: 10.1016/j.biopsych.2014.08.001. Epub 2014 Aug 13.


Reduced cognition in Syngap1 mutants is caused by isolated damage within developing forebrain excitatory neurons.

Ozkan ED, Creson TK, Kramár EA, Rojas C, Seese RR, Babyan AH, Shi Y, Lucero R, Xu X, Noebels JL, Miller CA, Lynch G, Rumbaugh G.

Neuron. 2014 Jun 18;82(6):1317-33. doi: 10.1016/j.neuron.2014.05.015.


Methamphetamine-associated memory is regulated by a writer and an eraser of permissive histone methylation.

Aguilar-Valles A, Vaissière T, Griggs EM, Mikaelsson MA, Takács IF, Young EJ, Rumbaugh G, Miller CA.

Biol Psychiatry. 2014 Jul 1;76(1):57-65. doi: 10.1016/j.biopsych.2013.09.014. Epub 2013 Oct 31.

Supplemental Content

Loading ...
Support Center